Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02623959 · ClinicalTrials.gov registry record · Phase 4
Indwelling Pleural Catheter With Either Doxycycline or Saline at Day 7 for Pleurodesis
A Phase 4 study, sponsored by M.D. Anderson Cancer Center.
- Terminated
- Registry status
- Phase 4
- Development phase
- 3
- Enrollment target
NCT02623959: Clinical Trial Phase 4 study, sponsored by M.D. Anderson Cancer Center.
NCT02623959 is a Phase 4 study that was terminated before completion, run by M.D. Anderson Cancer Center. The registered enrollment target is 3 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02623959, a Phase 4 study, was terminated before completion, sponsored by M.D. Anderson Cancer Center.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 3 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to compare indwelling pleural catheters (IPC) in combination with saline (the current standard of care) versus IPC in combination with doxycycline as treatment for pleural effusions.
Primary Outcome
This outcome will be analyzed by cause-specific hazard Cox model with treatment group as a covariate. Whenever a catheter is removed the cause for removal will be documented. For the analysis causes will include removal due to decreased drainage (i.e. as per plan) as well as removal due to complications (e.g. infection, empyema, and refractory pain) or other reasons (e.g. catheter plugged but no complication to the patient, patient preference without a complication).
Interventions
- OTHER Saline
- BEHAVIORAL Questionnaires
- DRUG Doxycycline
- DRUG Fentanyl (IV)
- DRUG Fentanyl Patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2016-04-27 |
| Est. Completion | 2017-05-23 |
| Phase | Phase 4 |
Why NCT02623959 stopped before completion
NCT02623959 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 5 interventions - of which Saline is the first listed.
NCT02623959 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02623959 about?
NCT02623959 is a clinical study titled "Indwelling Pleural Catheter With Either Doxycycline or Saline at Day 7 for Pleurodesis". The goal of this clinical research study is to compare indwelling pleural catheters (IPC) in combination with saline (the current standard of care) versus IPC in combination with doxycycline as treatment for pleural effusions.
What is the current status of trial NCT02623959?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 3 participants. The study started on 2016-04-27. Estimated completion is 2017-05-23.
What interventions are being tested in trial NCT02623959?
The interventions under investigation include: Saline (OTHER), Questionnaires (BEHAVIORAL), Doxycycline (DRUG), Fentanyl (IV) (DRUG), Fentanyl Patch (DRUG).
Who is sponsoring clinical trial NCT02623959?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02623959's enrollment target sits among peer trials
3 1995th of 2000 higher than 3 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI